+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Oncogene"

Proto Oncogene Protein C-akt Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Proto Oncogene Protein C-akt Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Myc Proto Oncogene Protein - Pipeline Insight, 2025 - Product Thumbnail Image

Myc Proto Oncogene Protein - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Proto-oncogene Protein C Mdm2 Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Proto-oncogene Protein C Mdm2 Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Proto Oncogene Protein C-myc Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Proto Oncogene Protein C-myc Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 96 Pages
  • Global
From
Proto Oncogene Proteins C Pim 1 Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Proto Oncogene Proteins C Pim 1 Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Proto-oncogene Protein C-bcl-2 Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Proto-oncogene Protein C-bcl-2 Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
From
NGS-Based RNA-Sequencing - Global Strategic Business Report - Product Thumbnail Image

NGS-Based RNA-Sequencing - Global Strategic Business Report

  • Report
  • April 2025
  • 196 Pages
  • Global
From
From
Tumor Marker Testing Market Report 2025 - Product Thumbnail Image

Tumor Marker Testing Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
From
From
Mesothelioma - Pipeline Insight, 2025 - Product Thumbnail Image

Mesothelioma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
RET (Ret Proto-Oncogene) Protein Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

RET (Ret Proto-Oncogene) Protein Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
CDK12 Inhibitor- Pipeline Insight, 2025 - Product Thumbnail Image

CDK12 Inhibitor- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Relapsed Or Refractory Myelodysplastic Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Relapsed Or Refractory Myelodysplastic Syndrome - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Gastric Cancer- Pipeline Insight, 2025 - Product Thumbnail Image

Gastric Cancer- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 550 Pages
  • Global
From
Loading Indicator

The Oncogene market is a subset of the Genomics market that focuses on the study of cancer-causing genes. Oncogenes are genes that have the potential to cause cancer when they are mutated or expressed at high levels. Oncogenes are studied to understand the molecular basis of cancer and to develop new treatments. Research in this field has led to the development of targeted therapies, such as monoclonal antibodies, small molecule inhibitors, and gene therapies. The Oncogene market is highly competitive, with many companies developing new technologies and treatments. Companies in the market include Illumina, Thermo Fisher Scientific, Qiagen, Agilent Technologies, and Bio-Rad Laboratories. Show Less Read more